Abstract Chlamydia pneumoniae is an obligate intracellular gram-negative bacterium, which causes respiratory infections in humans and may participate in the development of chronic diseases like atherosclerosis, chronic obstructive lung disease, adult-onset asthma and late-onset Alzheimer’s disease. It can infect various cell types, e.g. vascular endothelial cells, smooth muscle cells and monocyte-derived macrophages in vitro. It has been speculated that circulating macrophages disseminate the infection in the body, and that genetically susceptible individuals become chronically infected. Quantification of C. pneumoniae growth inside cultured cells is needed when studying e.g. the effect of drugs or host cell factors on infectivity and replication. Conventionally this has been done by immunofluorescence staining and microscopic counting of chlamydial inclusions. However, this method is usable only if the cell numbers do not fluctuate in cell culture vials and the inclusions are uniform. In macrophages, inclusions are often aberrant, their sizes vary and multiple inclusions are also seen. Therefore we developed a new method based on the real-time PCR quantification of chlamydial genomes adjusted to the number of human genomes and used it to quantify the exact amounts of C. pneumoniae in infected cells. The susceptibility of monocyte-macrophages from healthy individuals to C. pneumoniae infection in vitro was studied first. Intracellular growth of C. pneumoniae was used as an indicator of susceptibility to infection, and it was compared to serum levels of CRP, soluble CD14, human HSP-IgG, human HSP-IgA, C. pneumoniae IgG and IgA antibodies. The growth of C. pneumoniae in infected macrophages was highly variable, ranging from 0 to 638 chlamydial genomes per human genome. C. pneumoniae growth associated positively with serum C. pneumoniae IgA (titer ≥10) and hHSP-IgG and negatively with soluble CD14 concentration. The association between chlamydial IgA antibodies, hHSP-IgG and C. pneumoniae growth was statistically significant only among men. Age did not correlate with the growth. Therefore we hypothesize that persons whose macrophages cannot restrict the growth of C. pneumoniae are more prone to chronic infection by this agent. In the next study, we evaluated the effects of innate immunity genes CD14 -260 C>T, TLR2 Arg753Gln, TLR4 Asp299Gly, LBP Phe436Leu and IL-6 -174 G>C polymorphisms on C. pneumoniae growth in human macrophages in vitro. The growth of C. pneumoniae was highest in CD14 -260 C>T TT genotype cells and the difference to CC or CT genotype was statistically significant. The G-allele of the IL6 -174 G>C polymorphism had a positive influence on chlamydial growth; the difference was statistically significant only between CC and GC genotypes. TLR2 Arg753Gln, TLR4 Asp299Gly, LBP Phe436Leu polymorphisms showed no effect on chlamydial growth.

Submitted by Luciana Ferreira (lucgeral@gmail.com) on 2015-05-18T12:21:04Z No. of bitstreams: 2 Dissertação - Arissa Felipe Borges - 2013.pdf: 8506033 bytes, checksum: 5e9de67542df7e057a413d653adfb783 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) / Approved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2015-05-18T13:20:11Z (GMT) No. of bitstreams: 2 Dissertação - Arissa Felipe Borges - 2013.pdf: 8506033 bytes, checksum: 5e9de67542df7e057a413d653adfb783 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) / Made available in DSpace on 2015-05-18T13:20:11Z (GMT). No. of bitstreams: 2 Dissertação - Arissa Felipe Borges - 2013.pdf: 8506033 bytes, checksum: 5e9de67542df7e057a413d653adfb783 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) Previous issue date: 2013-02-28 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES / Fundação de Amparo à Pesquisa do Estado de Goiás - FAPEG / Conselho Nacional de Pesquisa e Desenvolvimento Científico e Tecnológico - CNPq / The platelet activating factor (PAF) is produced by macrophages during inflammation and infection. The role of PAF in leishmaniasis, a disease caused by the protozoan Leishmania spp is not yet fully elucidated. This study was aimed to evaluate the modulation of human macrophage infection with L. (V.) braziliensis by PAF. Monocyte-derived macrophages were incubated with promastigote forms and the infection was assessed under light microscopy (infection index = % infected macrophages x the mean number of parasites per macrophage) after 4 h or 48 h incubation. The NBT assay was used to evaluate the production of superoxide anion. Treatment with PAF 10-10 M, 3 h before the addition of the parasites, increased infection index after 4 h of incubation (Medium vs PAF: 212 vs 324, p <0.05), whereas the infection decreased after 48 h of incubation when PAF was added together with parasites (554 vs 181, p <0.05). The effect of PAF seems to be on macrophages and not on parasites, since the treatment of parasites before incubation with the cells decreased the infection index after 4 h (p <0.05). It was observed that treatment of macrophages with rIFNg, PAF and LPS simultaneously intensified the decreasing of infection index, but the results were not significantly different of those from cultures treated with only PAF. Treatment of macrophages with a PAF antagonist, PCA 4248, 30 min before incubation with the parasites caused a significant increase of the infection index in a concentration-dependent manner (p <0.05) after 48 h. The effect of PCA 4248 was observed only when it was present during the first 4 h of incubation. The inhibition of the reactive oxygen intermediates (ROI) and nitric oxide (NO) production with apocynin and aminoguanidine, respectively, increased the infection (Medium vs apocynin: 200 vs 501; vs Aminoguanidine: 389, p <0.05). In parallel, it was showed that L. (V.) braziliensis induces the production of ROI (superoxide anion) which is further increased by exogenous or endogenous PAF. In conclusion, PAF modulates phagocytosis and increases the microbicidal activity depending on the concentration, contributing to the control of the human macrophage infection with L. (V.) braziliensis. The data showed that Leishmania (V.) braziliensis induces the production of ROI and NO in human macrophages, and suggested that PAF-enhanced microbicidal activity is mediated by an increased production of ROI. The data indicate that PAF activates human macrophages, and can play an important role in the control of the infection by L. (V.) braziliensis. / O fator ativador de plaquetas (PAF) é produzido por macrófagos durante a inflamação e infecções. O papel do PAF na leishmaniose, doença causada pelo protozoário Leishmania spp ainda não está completamente elucidado. Neste trabalho foi avaliado se o PAF é capaz de modular a infecção de macrófagos humanos com L. (V.) braziliensis. Macrófagos foram derivados de monócitos e incubados com formas promastigotas, sendo a infecção avaliada sob microscopia de luz (Índice de infecção = % macrófagos infectados x número médio de parasitos por macrófagos), após 4 h ou 48 h de incubação. O ensaio do NBT foi utilizado para avaliar a produção de ânion superóxido. O tratamento com o PAF 10-10 M, 3 h antes da adição dos parasitos, aumentou o índice de infecção após 4 h de incubação (Meio vs PAF: 212 vs 324, p < 0,05), enquanto diminuiu este índice após 48 h de incubação, quando o PAF foi adicionado junto com os parasitos (554 vs 181, p < 0,05). O efeito do PAF parece ser nos macrófagos e não nos parasitos, uma vez que o tratamento dos parasitos antes da incubação com as células diminuiu significantemente a infecção após 4 h (p < 0,05). Foi observado que o tratamento dos macrófagos com rIFNg, PAF e LPS simultaneamente, apesar de causar uma redução mais acentuada nos índices de infecção, não mostrou diferença estatisticamente significativa em relação ao tratamento com o PAF sozinho. O tratamento dos macrófagos com um antagonista de PAF, o PCA 4248, 30 min antes da incubação com os parasitos causou um aumento significante do índice de infecção, de maneira dependente da concentração (p < 0,05), após 48 h. O efeito do PCA 4248 foi observado somente quando este estava presente durante as primeiras 4 h de incubação. A inibição da produção de reativos intermediários do oxigênio (ROI) e óxido nítrico (NO), com apocinina e aminoguanidina, respectivamente, aumentou a infecção (Meio vs Apocinina 10-3 M: 200 vs 501; vs Aminoguanidina 10-3 M: 389, p < 0,05). Em paralelo, a quantificação da produção de ânion superóxido, demonstrou que L. (V.) braziliensis induz a produção de ROI e que esta produção pode ser aumentada pelo PAF exógeno ou endógeno. Em conclusão, o PAF modula a fagocitose e aumenta a atividade microbicida, dependendo da concentração, contribuindo para o controle da infecção de macrófagos humanos com L. (V.) braziliensis. A infecção de macrófagos humanos com L. (V.) braziliensis induz a produção de ROI e NO, sendo sugerido que o PAF aumenta a atividade microbicida dos macrófagos via aumento da produção de ROI. Os dados indicam que o PAF ativa os macrófagos humanos, podendo ser relevante no controle da infecção por L. (V.) braziliensis.

The inflammatory and anti-inflammatory macrophages have been implicated in many diseases including rheumatoid arthritis, inflammatory bowel disease and chronic rhinosinusitis. Recent studies suggest targeting macrophage function and activation may represent a potential target to treat these diseases. Herein, I investigated the effect of second mitochondria-derived activator of caspases (SMAC) mimetics (SMs), the inhibitors of apoptosis (IAPs) proteins, on the killing of normal human pro- and anti-inflammatory macrophage subsets. It has been shown that human monocytes are highly susceptible to the cytotoxic effects of SMs, however, differentiated macrophages (M0) develop resistance to the cytocidal abilities of SMs. Whether human macrophage subsets are also resistant to the cytotoxic effects of SM remains unknown. My results show that differentiation of M0 macrophages towards M1 state rendered them highly susceptible to SM-induced cell death, whereas M2a, M2b and M2c differentiated subsets were resistant, with M2c being the most resistant. SM-induced cell death in M1 macrophages was mediated by apoptosis as well as necroptosis and activated both extrinsic and intrinsic pathways of apoptosis. The susceptibility of M1 macrophages to SM-induced cell death was attributed to the IFN-𝛾-mediated polarization as JAK inhibitor reversed their susceptibility. In contrast, M2c and M0 macrophages experienced cell death through necroptosis pathway following simultaneous blockage of the IAPs pathways by SM-LCL161 and the caspase pathways by the pan-caspase inhibitors (zVAD.fmk). I investigated the molecular mechanism governing SM-induced cell death in M1 macrophages. My results show that in contrast to the cancer cell lines, SM-induced cell death in M1 macrophages is independent of endogenously produced TNF-⍺, the canonical and non- canonical NF-𝜅B pathways. The susceptibility of M1 macrophages to SM-induced cell death was found to be dependent on IFN-𝛾-mediated differentiation through the JAK-STAT pathway and subsequent activation of IRF-1. In addition, the selective cell death in SM-treated M1 macrophages is mediated by simultaneous degradation of cellular IAP-2 (cIAP-2) and RIPK-1/3 through the activation of mTORC signaling pathway. Overall, the results suggest that survival of human macrophages is critically linked to the activation of the IAPs pathways. Moreover, agents blocking cIAP-1/2, mTORC and IRF-1 can be exploited therapeutically to address inflammation-related diseases. These observations hold a promising therapeutic strategy to limit the activation of proinflammatory M1 macrophages and eventually controlling the M1-associated diseases.

No description available.

Dynamic alterations of composition and mechanics of the extracellular matrix (ECM) are suggested to modulate cellular behavior including plasticity of macrophages (MPhs) during wound healing. In this study, engineered 3D fibrillar matrices based on naturally occurring biopolymers (collagen I, glycosaminoglycans (GAGs)) were used to mimic matrix stiffening as well as modification by sulfated and non-sulfated GAGs at different stages of wound healing. Human MPhs were found to sensitively respond to these microenvironmental cues in terms of polarization towards pro-inflammatory or wound healing phenotypes over 6 days in vitro. MPhs exhibited a wound healing phenotype in stiffer matrices as determined by protein and gene expression of relevant cytokines (IL10, IL12, TNF). Presence of sulfated and non-sulfated GAGs inhibited this polarization effect. Furthermore, control experiments on 2D matrices stressed the relevance of using stiffness-controlled 3D matrices, as MPhs showed a reciprocal polarization behavior depending on GAG presence. Hence, the results indicate a strong influence of dimensionality, stiffness, and GAG presence of the biomaterial scaffold on MPh polarization and emphasize the need for matrices closely mimicking the 3D in vivo context with a variable stiffness and GAG composition in in vitro studies.

Charles University in Prague Faculty of Pharmacy in Hradec Králové Department of Pharmacology & Toxicology Student: Alžbeta Horvátová Supervisor: prof. PharmDr. Petr Pávek PhD. Title of diploma thesis: Anti-inflammatory effects of ursodeoxycholyl lysophosphatidylethanolamide on THP-1 human macrophages via Toll-like receptor 4 Nonalcoholic steatohepatitis (NASH) became the most common liver disease in developed countries. It is well-known that the level of protectant phosphatidylcholine (PC) is decreased in NASH. The bile acid-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide (UDCA-LPE) was designed in order to specifically deliver PC to hepatocytes. However, previous studies have proved that UDCA-LPE possesses its proper hepatoprotectant capacity and exhibits anti-apoptotic, anti-inflammatory, anti-fibrotic properties and also improved steatosis and hyperlipidaemia in various models in vivo. These effects may be mediated secondary through modulation of immune system. Therefore, in order to dissect if UDCA-LPE directly influences immune cells in vitro, release of pro-inflammatory cytokines TNFα, IL-6 and IL-1β in LPS-induced THP-1-derived human macrophages was measured by ELISA. Moreover, effects of UDCA-LPE on MAPK signalling pathways and nuclear translocation of NFκB were...

Tuberculosis remains a major public health problem and one of the leading causes of death worldwide. Human genetic factors determine susceptibility to M. tuberculosis (M. tb) infection and predispose to clinical TB. Genome-wide association studies (GWAS) aim to discover human genes associated with susceptibility to TB. Recently, a GWAS conducted by our lab identified a new TB-associated gene ASAP1 that encodes an Arf GTPase-activating protein (GAP). ASAP1 is known to be involved in regulation of actin and membrane remodeling. My Ph.D. included three projects. In my first project, I used RNAi and CRISPR-Cas9 technologies to study the role of ASAP1 in dendritic cells and macrophages, cells that play critical roles during mycobacterial infection. I demonstrated that in these cells ASAP1 is essential for migration and phagocytosis of mycobacteria. I characterized proteins that ASAP1 interacts with during mycobacterial infection. Finally, I found that the ASAP1-mediated pathway regulates expression of a large number of the immune response genes. These findings emphasize the important role of ASAP1 in mycobacterial infection and explain its involvement in TB pathogenesis. In my second project, I was involved in a large study conducted by our laboratory that characterized transcriptional responses to M. tb infection in macrophages from a cohort of 144 healthy subjects. We used RNA-Seq to study transcriptomes of the infected and non-infected macrophages and identified differentially expressed genes. We also genotyped DNA polymorphisms of these subjects and studied the association between genetic variants and levels of gene expression, which allows us to identify expression quantitative trait loci (eQTLs), i.e., DNA polymorphism that affect gene expression. In particular, we identified an eQTL located in the TLR10-TLR1-TLR6 gene cluster. In non-infected macrophages, a group of polymorphisms in this region was associated in cis with the level of expression of TLR1, but not of the other two TLR genes. In M. tb-infected macrophages the same polymorphisms were associated in trans with levels of expression of 37 genes. This network includes essential immune response proteins, including multiple cytokines and chemokines. The discovery of this TLR1-driven network will help to better understand mechanisms of macrophage responses to mycobacterial infection. Our study also identified a DNA polymorphism located upstream of the ARHGAP27 gene, regulating its expression in infected and non-infected macrophages. In our GWAS this polymorphism was associated with TB risk, which implicated ARHGAP27 in TB pathogenesis. The ARHGAP27 protein is a Rho-GAP involved in the endocytic pathway. In my third project, I used CRISPR technology to establish the ARHGAP27-knockout macrophage cell model and characterized the function of ARHGAP27, showing that it is involved in cell migration and phagocytosis of mycobacteria. Taken together, my studies highlighted functional mechanisms implicating TB-associated GAP proteins ASAP1 and ARHGAP27 in mycobacterial infection and TB pathogenesis.

Ο S. epidermidis αποτελεί κύριο μέλος της χλωρίδας του δέρματος και των βλεννογόνων του ανθρώπου, ενώ συνιστά ένα από τα συχνότερα παθογόνα που προκαλούν νοσοκομειακές λοιμώξεις, ιδιαίτερα σε ανοσοκατασταλμένους ή ασθενείς φέροντες προσθετικά υλικά. Κύριος λοιμογόνος παράγοντας του S. epidermidis είναι ο σχηματισμός βιομεμβράνης. Διάφοροι πολυσακχαρίτες έχουν απομονωθεί από την εξωκυττάρια ουσία του S. epidermidis και έχουν συσχετισθεί με το σχηματισμό βιομεμβράνης καθώς και με την παθογόνο δράση τους. Ο πλέον μελετημένος και εδραιωμένος είναι ο ΡΙΑ, ενώ οι άλλοι πολυσακχαρίτες (PS/A ή PNSG ή PNAG και το SSA) απεδείχθησαν τελικώς ότι είναι ταυτόσημοι ή χημικώς ανάλογοι του ΡΙΑ. Ο ΡΙΑ είναι μία ομογλυκάνη αποτελούμενη από μονάδες Ν-ακετυλογλυκοζαμίνης συνδεδεμένες με β-1,6-γλυκοζιτικό δεσμό και η σύνθεσή του ελέγχεται από ένζυμα που κωδικοποιούνται από τον icaADBC γενετικό τόπο. Η εξωκυττάρια ουσία του S. epidermidis περιέχει επίσης έναν πολυσακχαρίτη, τον 20-kDaPS, ο οποίος απομονώθηκε από ερευνητές του Πανεπιστημίου Πατρών και αποτελείται κυρίως από γλυκόζη, Ν-ακετυλογλυκοζαμίνη, και είναι μερικώς θειωμένος. Ο 20-kDaPS αντιορός αναστέλλει την προσκόλληση του S. epidermidis στα ενδοθηλιακά κύτταρα και την εμφάνιση βακτηριακής κερατίτιδας σε κουνέλια. Με βάση αναλύσεις κλινικών στελεχών, ο 20-kDaPS εκφράζεται σε μεγάλο ποσοστό στελεχών S. epidermidis, ενώ δεν ανευρέθηκε σε στελέχη άλλων πηκτάση αρνητικών σταφυλοκόκκων. Η παρεμβολή αλληλουχιών εισδοχής σε διάφορα σημεία του icaADBC οπερονίου, το οποίο ελέγχει τη σύνθεση του ΡΙΑ, δεν παρεμβάλλεται στην έκφραση του 20-kDaPS. Η κατεργασία βακτηριακών κυττάρων S. epidermidis με το ένζυμο dispersin B, το οποίο διασπά ειδικά τον β-1,6-γλυκοζιτικό δεσμό που συνθέτει το πολυμερές του ΡΙΑ, και με μετα-περιοδικό νάτριο που διασπά το δεσμό μεταξύ των ατόμων άνθρακα C-3 και C-4 των μονομερών Ν-ακετυλογλυκοζαμίνης, οδηγεί σε διάσπαση της βιομεμβράνης, χωρίς όμως να διαφοροποιείται αντιγονικά ο 20-kDaPS. Τα κλάσματα, μετά την έκλουση της εξωκυττάριας ουσίας του S. epidermidis από στήλη Q-Sepharose, που εμφανίζουν τη μεγαλύτερη ανοσοδραστικότητα για τον ΡΙΑ, στερούνται πλήρως 20-kDaPS. Η προεπώαση κλινικού στελέχους που δεν εκφράζει τον 20-kDaPS με τον πολυσακχαρίτη αναστέλλει την ενδοκυττάρωση, ενώ η προεπώαση του πρότυπου στελέχους ATCC35983 που συνθέτει τον 20-kDaPS με ειδικό αντιορό ενισχύει την ενδοκυττάρωση από τα ανθρώπινα μακροφάγα. Κατά συνέπεια, ο icaADBC γενετικός τόπος δεν εμπλέκεται στη σύνθεση του 20-kDaPS. Οι ανοσοχημικές και χρωματογραφικές ιδιότητες του PIA και του 20-kDaPS είναι διακριτές. Ο 20-kDaPS πιθανό να επιδεικνύει αντιφαγοκυτταρική δράση, ενώ τα ειδικά αντισώματα έχουν δράση οψωνίνης. Η οργάνωση των βακτηρίων εντός βιομεμβράνης προστατεύει από τις αντιμικροβιακές ουσίες και το σύστημα ανοσίας. Τα βακτήρια εντός βιομεμβράνης περιέχουν στην εξωκυττάρια ουσία τους μεγαλύτερα ποσά ΡΙΑ από τα ελεύθερα αναπτυσσόμενα, πλαγκτονικά κύτταρα. Τα βακτήρια εντός βιομεμβράνης επιδεικνύουν μεγαλύτερη ικανότητα για προσκόλληση και επιβίωση εντός των ανθρώπινων μακροφάγων από τα πλαγκτονικά κύτταρα. Τα βακτήρια εντός βιομεμβράνης επάγουν την παραγωγή μικρότερων ποσών φλεγμονωδών κυτταροκινών, όπως ο TNFα, καθώς και Th1 κυτταροκινών, όπως οι IL-12p40, IL-12p70 and IFN-γ, ενώ ενισχύουν τις IL-8, GM-CSF και IL-13. Οι συγκεκριμένες παρατηρήσεις αφορούν ζωντανά βακτηριακά κύτταρα καθώς και βακτηριακά κύτταρα μονιμοποιημένα με φορμαλδεΰδη. Τα ανωτέρω δεδομένα συνάδουν με την ήπια συμπτωματολογία των σχετιζόμενων με βιομεμβράνη λοιμώξεων S. epidermidis και τη διαφυγή της επιτήρησης του ανοσολογικού συστήματος. Συμπερασματικά, ο 20-kDaPS αποτελεί κύριο συστατικό της εξωκυττάριας ουσίας του S. epidermidis με αντιφαγοκυτταρικές και ανοσορρυθμιστικές ιδιότητες. Οι ανοσοχημικές και χρωματογραφικές ιδιότητες του 20-kDaPS είναι πλήρως διακριτές του ΡΙΑ, του κύριου πολυσακχαρίτη που σχετίζεται με το σχηματισμό βιομεμβράνης, ενώ ο γενετικός τόπος icaADBC δε ρυθμίζει τη σύνθεση του 20-kDaPS. Η οργάνωση των βακτηρίων εντός βιομεβράνη εξασφαλίζει αντίσταση στην ενδοκυττάρια θανάτωσή τους από τα μακροφάγα και καταστολή της ανοσιακής απόκρισης. / The skin commensal and opportunistic pathogen Staphylococcus epidermidis is a leading cause of hospital-acquired and biomaterial-associated infections. The polysaccharide intercellular adhesin (PIA), a homoglycan composed of β-1,6-linked N-acetylglucosamine residues, synthesized by enzymes encoded by the icaADBC operon is a major functional factor in biofilm accumulation, promoting virulence in experimental biomaterial-associated S. epidermidis infections. Extracellular mucous layer extracts of S. epidermidis contain another major polysaccharide, referred to as 20-kDa polysaccharide (20-kDaPS), composed mainly out of glucose, N-acetylglucosamine, and being partially sulfated. 20-kDaPS antiserum prevents adhesion of S. epidermidis on endothelial cells and development of experimental keratitis in rabbits. Here we provide experimental evidence that 20-kDaPS and PIA represent distinct molecules and that 20-kDaPS is implicated in endocytosis of S. epidermidis bacterial cells by human monocyte-derived macrophages. Analysis of 75 clinical coagulase-negative staphylococci from blood-cultures and central venous catheter tips indicated that 20-kDaPS is expressed exclusively in S. epidermidis but not in other coagulase-negative staphylococcal species. Tn917-insertion in various locations in icaADBC in mutants M10, M22, M23, and M24 of S. epidermidis 1457 are abolished for PIA synthesis, while 20-kDaPS expression appears unaltered as compared to wild-type strains using specific anti-PIA and anti-20-kDaPS antisera. While periodate oxidation and dispersin B treatments abolish immuno-reactivity and intercellular adhesive properties of PIA, no abrogative activity is exerted towards 20-kDaPS immunochemical reactivity following these treatments. PIA polysaccharide I-containing fractions eluted from Q-Sepharose were devoid of detectable 20-kDaPS using specific ELISA. Preincubation of non-20-kDaPS-producing clinical strains with increasing amounts of 20-kDaPS inhibits endocytosis by human macrophages, whereas, preincubation of 20-kDaPS-producing strain ATCC35983 with 20-kDaPS antiserum enhances bacterial endocytosis by human macrophages. In conclusion, icaADBC is not involved in 20-kDaPS synthesis, while the chemical and chromatographic properties of PIA and 20-kDaPS are distinct. 20-kDaPS exhibits anti-phagocytic properties, whereas, 20-kDaPS antiserum may have a beneficial effect on combating infection by 20-kDaPS-producing S. epidermidis. As stated above, biofilm formation is a major virulence factor of S. epidermidis. Biofilm protects bacterial cells from antimicrobial agents and components of the immune system. Interactions of peripheral blood mononuclear cells and monocyte derived macrophages with planktonic or biofilm phase S. epidermidis cells were also studied. Biofilm phase bacteria exhibited higher attachment, as well as, a ten fold higher intracellular survival in monocyte-derived macrophages than their planktonic counterparts. Stimulation of peripheral blood mononuclear cells and monocyte derived macrophages was performed with live or formalin-fixed bacterial cells. Supernatant concentration of selected cytokines was measured by Luminex® xMAP™ technology at different time points. As compared to planktonic phase, biofilm phase bacteria elicited lower amounts of proinflammatory cytokines and Th1 response cytokines, such as TNFα, IL-12p40, IL-12p70 and IFN-γ, whereas, they enhanced production of IL-8, GM-CSF and IL-13. This phenomenon was independent of formalin pretreatment. Taken together, these results may contribute to interpretation of observed silent course of biofilm associated infections. In conclusion, 20-kDaPS represents a major component of S. epidermidis extracellular matrix and data show that 20-kDaPS posseses antiphagocytic and immunomodulatory properties. 20-kDaPS and PIA are immunochemically and chromatographically discrete molecules, whereas icaADBC locus is not involved in 20-kDaPS synthesis. Biofilm mode of growth ensures higher resistance rates to intracellular killing and down regulation of immune responses.

Mémoire numérisé par la Division de la gestion de documents et des archives de l'Université de Montréal.

Dentre as 18 espécies do gênero Yersinia, as espécies Y. enterocolitica, Y. pseudotuberculosis e Y. pestis foram extensivamente caracterizadas em diversos aspectos como ecologia, epidemiologia e mecanismos de patogenicidade. Sete das 15 espécies restantes (Y. aldovae, Y. bercovieri, Y. frederiksenii, Y. intermedia, Y. kristensenii, Y. mollaretii e Y. rohdei), usualmente conhecidas como Y. enterocolitica-like, até o momento, não tiveram seu potencial patogênico caracterizado e são, geralmente, consideradas não-patogênicas. Entretanto, dados da literatura sugerem que algumas dessas espécies possam causar doença. Esses dados estimularam o surgimento de questões sobre os mecanismos pelos quais as espécies de Y. enterocolitica-like possam interagir com as células do hospedeiros e causar doenças. Esse projeto teve como principal objetivo caracterizar o potencial patogênico de linhagens de Y. enterocolitica-like, especificamente das espécies Y. frederiksenii, Y. kristensenii e Y. intermedia. No presente trabalho, o potencial patogênico de 118 linhagens de Y. enterocolitica-like (50 Y. frederiksenii, 55 Y. intermedia e 13 Y. kristensenii) foi avaliado pela pesquisa da presença dos genes relacionados à virulência ail, fepA, fepD, fes, hreP, myfA, tccC, ystA, ystB e virF por PCR. Além disso, a habilidade de algumas linhagens de Yersinia de aderir e invadir células Caco-2 e HEp-2 após diferentes períodos de incubação, bem como, de sobreviver no interior de macrófagos humanos U937 foi testada. Aspectos morfológicos da adesão bacteriana foram visualizados por microscopia eletrônica. Finalmente, a presença de possíveis novos mecanismos de virulência foi avaliada a partir do sequenciamento de RNA de uma linhagem de Y. enterocolitica-like. As linhagens estudadas apresentaram os seguintes genes: Y. frederiksenii, fepA (44%), fes (44%) e ystB (18%); Y. intermedia, ail (53%), fepA (35%), fepD (2%), fes (97%), hreP (2%), ystB (2%) e tccC (35%); e Y. kristensenii, ail (62%), ystB (23%), fepA (77%), fepD (54%), fes (54%) e hreP (54%). De modo geral, as linhagens de Y. enterocolitica-like tiveram a habilidade de aderir e invadir células Caco-2 e HEp-2 inferior à da linhagem altamente patogênica Y. enterocolitica 8081. Contudo, Y. kristensenii FCF 410 e Y. frederiksenii FCF 461 apresentaram elevado potencial de invasão a células Caco-2 após cinco dias de pré-incubação, os quais foram 45 e 7,2 vezes maiores do que o controle Y. enterocolitica 8081, respectivamente, porém, o gene ail não foi detectado nessas linhagens. O ensaio de sobrevivência em macrófagos humanos U937 ii mostrou que as linhagens de Y. frederiksenii FCF 461 (40,0%) e Y. frederiksenii FCF 379 (24,6%) tiveram porcentagens de sobrevivência superior à de Y. enterocolitica 8081 (13,4%). Todavia, linhagens de Y. intermedia e Y. kristensenii apresentaram uma capacidade reduzida de sobreviver em macrófagos. A microscopia eletrônica de varredura mostrou as bactérias em contato com a filipódia celular. As bactérias foram distribuídas tanto individualmente quanto em pequenos aglomerados. Portanto, podemos concluir que a presença dos genes relacionados à virulência encontrados nas Y. enterocolitica-like estudadas indicou o possível potencial patogênico de algumas dessas linhagens. Os ensaios de adesão e invasão a células de mamíferos sugerem que a patogenicidade de Y. kristensenii e Y. frederiksenii possa ser linhagem-dependente. O ensaio de sobrevivência em macrófagos humanos U937 evidenciou o potencial patogênico de algumas linhagens de Y. frederiksenii. Em conjunto, os resultados obtidos sugerem a existência de mecanismos de virulência alternativos aos mecanismos clássicos descritos para Y. enterocolitica patogênica. Contudo, a presença de possíveis novos mecanismos de virulência não pode ser verificada, uma vez que a plataforma 454 GS Junior (Roche) não se mostrou adequada para a realização de sequenciamento de RNA de amostras provenientes de interações com células devido à baixa cobertura obtida. / Among the 18 species of the Yersinia genus, Y. enterocolitica, Y. pseudotuberculosis and Y. pestis were extensively characterized in different subjects as ecology, epidemiology and pathogenicity mechanisms. Seven among the remaining 15 species (Y. aldovae, Y. bercovieri, Y. frederiksenii, Y. intermedia, Y. kristensenii, Y. mollaretii and Y. rohdei), often called Y. enterocolitica-like have not their pathogenic potential characterized and are usually considered to be nonpathogenic. However, literature data suggest that some of these species can cause diseases. These data stimulate the upsurge of questions about the mechanisms of which Y. enterocolitica-like species may interact with host cells and cause diseases. The main objective of this preject was to characterize the pathogenic potential of Y. enterocolitica-like strains, specifically of the species Y. frederiksenii, Y. kristensenii and Y. intermedia. This work evaluated the pathogenic potential of 118 Y. enterocolitica-like strains (50 Y. frederiksenii, 55 Y. intermedia and 13 Y. kristensenii) searching for the presence of the virulence-related genes ail, fepA, fepD, fes, hreP, myfA, tccC, ystA, ystB and virF by PCR. Besides, Yersinia strains ability of adhesion and invasion to Caco-2 and HEp-2 cells after different pre-incubation periods, and its survival within human macrophages U937 were tested. Morphologic aspects of bacterial adhesion were observed by scanning electronic microscopy. Finally, the presence of new possible virulence mechanisms was evaluated through RNA sequencing of one Y. enterocolitica-like strain. The studied strains showed the following genes: Y. frederiksenii, fepA (44%), fes (44%) and ystB (18%); Y. intermedia, ail (53%), fepA (35%), fepD (2%), fes (97%), hreP (2%), ystB (2%) and tccC (35%); and Y. kristensenii, ail (62%), ystB (23%), fepA (77%), fepD (54%), fes (54%) and hreP (54%). Usually Y. enterocolitica-like strains presented less ability of adhere and invade Caco-2 and HEp-2 cells than the highly pathogenic strain Y. enterocolitica 8081. On the other hand, Y. kristensenii FCF 410 and Y. frederiksenii FCF 461 showed high potential of invasion in Caco-2 cells after 5 days of pre-incubation, which were 45 and 7.2 times higher than the control Y. enterocolitica 8081 respectively, but ail gene was not found in these strains. Survival assay in human macrophages U937 showed that Y. frederiksenii FCF 461 (40.0%) and Y. frederiksenii FCF 379 (24.6%) strains presented survival percentages higher than Y. enterocolitica 8081 (13.4%). However, Y. intermedia and Y. iv kristensenii strains showed a reduced capability of surviving in macrophages. Scanning electron microscopy showed bacteria at the surface in contact with the cellular filopodia. The bacteria were distributed either individually or in small clumps. Therefore, it may be concluded that the presence of virulence-related genes in some of the Y. enterocolitica-like strains indicated their possible pathogenic potential. Mammal cells adhesion and invasion assays suggest that the pathogenicity of Y. kristensenii and Y. frederiksenii may be strain-dependent. Human macrophages U937 surviving assay highlighted the pathogenic potential of some Y. frederiksenii strains. Together, the results suggest the existence of alternative virulence mechanisms other than the classical mechanisms described for pathogenic Y. enterocolitica. However, we could not verify the presence of possible new virulence mechanisms because 454 GS Junior (Roche) platform was not suitable for RNA sequencing of strains from cells interaction due its low coverage obtained.